Eurazeo / 2019 Universal Registration Document

Financial Statements Consolidated Financial Statements for the year ended December 31, 2019

EQUITY AND EARNINGS PER SHARE NOTE 12

Total Equity 12.1. Equity attributable to owners of the Company is €5,016 million, or €65.85 per share, as of December 31, 2019. The Eurazeoshare price was €61.00 per share as of December 31, 2019. Share capital 12.1.1. As of December 31, 2019, the share capital was €239,869 thousand, comprising 78,645,486 fully paid-up shares of two classes: 78,621,469 ordinary shares and 24,017 preferenceshares. Eurazeo holds 2,481,267 of its ownshares as of December 31, 2019.

Dividends paid 12.1.2.

2019

2018

(In euros)

Totaldividenddistribution

91,550,948 89,793,770

DIVIDENDPER SHARE PAID IN CASH

1.25

1.25

The Shareholders' Meeting of April 25, 2019 approved the distribution of a dividend of €1.25 per share. The total distribution to shareholders was therefore €91,551 thousand. In addition, a bonus share issue of one free share for 20 shares held was performed.

Non-controllinginterests 12.1.3. Non-controllinginterestsbreak down bystrategy inthe balance sheetand incomestatement as follows:

12/31/2019

12/31/2018

(In thousandsof euros)

Investment andassetmanagementactivities

96,777

82,712

Eurazeo Capital

1,122,020

738,818 261,992 112,951

Eurazeo PME

261,194 123,144 12,465

Eurazeo Patrimoine

Eurazeo Brands

6,974

NON-CONTROLLING INTERESTS

1,615,599

1,203,447

2019

2018

(In thousandsof euros)

Investment andassetmanagementactivities

25,720

28,294 (56,121) (19,628)

Eurazeo Capital

(15,003) (18,621)

Eurazeo PME

Eurazeo Patrimoine

17,739

6,315 (102)

Eurazeo Brands

86

NETINCOME(LOSS)ATTRIBUTABLETONON-CONTROLLING INTERESTS

9,920

(41,242)

the Seqens group is controlled by Eurazeo. It is a major player • in pharmaceuticalsynthesis and the specialty chemicals industry. Investment partners at Eurazeo group level are entitled to 53.28% of this group'snet income; the WorldStrides group is controlled by Eurazeo. It is a leader • in educational travel. Investment partners at Eurazeo group level are entitledto 52.96% of this group'snet income;

The Group has identified four entities or sub-groups where non-controlling interestsare the mostmaterial: the DORC group is controlled by Eurazeo. It is one of the global • leading specialists of vitreoretinal surgery. Dorc designs, manufactures and distributes ophthalmic surgery equipment, consumables and instruments worldwide. Investment partners at Eurazeo group level are entitled to 22.74% of this group's net income; the Planet group is controlled by Eurazeo. Its main business • is helping travelers claim back VAT on retail purchases (Tax Free Shopping). Investment partners at Eurazeo group level are entitledto 31.55%of this group's netincome;

EURAZEO / 2019 UNIVERSAL REGISTRATION DOCUMENT

256